Skip to main content
. 2018 Oct 26;13(10):e0206416. doi: 10.1371/journal.pone.0206416

Fig 3. Neutralization of SFTSVpv by convalescent-phase mouse sera.

Fig 3

SFTSVpv were preincubated with 800-fold diluted mouse sera collected on Day 14 (120 mg/kg/day treatment group [(A) left columns] and 200 mg/kg/day treatment group [(B) right columns]). Subsequently, Vero cells were infected with SFTSVpv. Infectivity of SFTSVpv was determined by measuring luciferase activities at 24 h post infection. Results from three independent assays are shown, with error bars representing standard deviations. Significance was determined in comparison to the results from non-serum treatment or infectivity of VSVpv. ****, P < 0.0001; **, P < 0.01; * P < 0.05.